ADMA Biologics, Inc. (ADMA) vs Alvotech (ALVO)
A side-by-side comparison of ADMA Biologics, Inc. and Alvotech across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADMA
ADMA Biologics, Inc.
$10.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ALVO
Alvotech
$6.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADMA vs ALVO
growth of $100 · dividends reinvested · last 4yADMA +398.0% (+49.4%/yr)ALVO -45.4% (-14.0%/yr)ADMA compounded faster over this window
Log scale — wide-divergence pair
ADMA ALVO
ADMA vs ALVO: by the numbers
- •ADMA is the larger company ($2.34B vs $2.07B market cap).
- •ADMA is profitable (32.98% net margin) while ALVO runs a net loss (-36.51%).
- •ALVO grew revenue faster over the past five years (69.03% vs 54.55% CAGR).
Metrics side by side
Valuation
| Metric | ADMA | ALVO |
|---|---|---|
| P/E ratio | 14.44 | N/A |
| Forward P/E | 12.69 | N/A |
| P/S ratio | 4.57 | 4.20 |
| P/B ratio | 5.74 | N/A |
| EV / EBITDA | 10.67 | 41.84 |
| FCF yield | 4.97% | N/A |
Profitability
| Metric | ADMA | ALVO |
|---|---|---|
| Gross margin | 64.71% | 60.45% |
| Operating margin | 42.26% | 9.62% |
| Net margin | 32.98% | -36.51% |
| ROE | 41.39% | N/A |
| ROIC | 27.60% | 3.61% |
Growth (annualized)
| Metric | ADMA | ALVO |
|---|---|---|
| Revenue CAGR (5Y) | 54.55% | 69.03% |
| Total return CAGR (5Y) | 54.74% | N/A |
Frequently asked
- Which has grown faster, ADMA or ALVO?
- Over the past five years, ALVO grew revenue faster — ADMA at a 54.55% CAGR versus ALVO at 69.03%.
- Is ADMA or ALVO more profitable?
- ADMA runs the higher net margin — ADMA at 32.98% versus ALVO at -36.51%.
Go deeper
Dig into the metrics
ADMA Biologics P/E ratioADMA Biologics ROEAlvotech ROEADMA Biologics operating marginAlvotech operating marginADMA Biologics revenue growthAlvotech revenue growthADMA Biologics free cash flowAlvotech free cash flow
ADMA Biologics & Alvotech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.